Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric Cancer

NCT06736847 · tracked via the Priya Life Science China tracker

Sponsor

Jichao Qin

Phase

Observational

Started

2024-05-01

Last updated

2025-09-02

Condition(s) studied

Gastric Carcinoma

Investigational drug(s) / intervention(s)

distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer

distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer: distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer

Study summary

This study aims to evaluate lymph node metastasis and tumor deposit in the posterior gastric mesentery following distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer.

Eligibility

Sex

ALL

Min age

18 Years

Max age

85 Years

Healthy volunteers

Inclusion Criteria: 1. Aged older than 18 years and younger than 85 years 2. Primary gastric adenocarcinoma confirmed by preoperative pathology result 3. cT2-4N0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 7th Edition 4. Patients who received distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision 5. American Society of Anesthesiologists (ASA) class I, II, or III 6. Written informed consent Exclusion Criteria: 1. Negative preoperative biopsy 2. Too late tumour stage or metastasis (cT4b/M1) 3. BMI\>30 kg/m2 4. Total gastrectomy or proximal gastrectomy 5. previous neoadjuvant chemotherapy or radiotherapy 6. Previous upper abdominal surgery 7. Combined with other malignant diseases 8. Reject operation

Primary outcome measure(s)

Rate of lymph node metastasis and tumor deposit in the posterior gastric mesentery — through study completion, an average of 1 year

Trial sites (1)

Facility	City	Region	Status
Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	Zhejiang	Recruiting

More Jichao Qin trials in China

Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy Recruiting

The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy Recruiting

Validation of a Model for Predicting Duodenal Stump Leakage After Gastrectomy Active, not recruiting

Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer Recruiting

Mesogastrium Metastasis in Colon Cancer Recruiting

Other trials for the same condition

Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy Recruiting

The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy Recruiting

The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery Active, not recruiting

A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Starting soon

Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06736847 on ClinicalTrials.gov ↗ ← All trials in China